NCT02207504 2022-01-06Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate CancerDana-Farber Cancer InstitutePhase 1 Completed24 enrolled
NCT03136640 2021-10-19ModraDoc006/r in Metastatic Castration-resistant Prostate CancerModra PharmaceuticalsPhase 1 Completed23 enrolled
NCT01634061 2020-12-09Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) PatientsNovartisPhase 1 Completed43 enrolled